Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and bioavailability of modified-release levodopa-carbidopa in Parkinson's disease
2007-005033-11Phase 2Completed
- Sponsor
- CombinatoRx
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of levodopa + carbidopa in Parkinson's disease (PD) (2 arms), sponsored by CombinatoRx. Primary endpoints: Safety of Levodopa-Carbidopa XL Tablets and Bioavailability of modified-release levodopa-carbidopa formulations. Started Jan 2008; status: completed.
02
Drugs
levodopa + carbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2007-005033-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005033-11.